Past AlzForum Coverage:

1. International Conference on Alzheimer's & Parkinson's Diseases 2013
   • Tau, α-Synuclein Spread: Crazy Stuff—How Might It Work?
   • Like Star Born of Supernova, Plaque Born of Exploded Neuron?
   • Can Dousing PyroGlu-Aβ Treat Alzheimer’s Disease?
   • Field Ramps Up "Mini" Mouse MRI
   • LRRK Watchers’ Eyes Turn to Inflammation, Autophagy, Kinase
   • Can Cancer Therapy Be Neurodegenerative Wonder Drug?
   • Taking Aim at M1: Old Hat or New Target?
   • Dementia in Movement Disorders: What Causes It?
   • BACE Inhibitors Barrel Forward—Next Hurdles: Safety, Efficacy
   • In Pursuit of Toxic Tau
   • Sleep Patterns, Circadian Clock Linked to Aβ Oxidative Stress
   • From Natural History, A "Renaissance" for Amyloid Hypothesis
   • Longitudinal Data Stand Out at AD/PD Imaging Satellite
   • Brain Imaging in Trials—How to Make It Work?
   • First Stab at Combination Therapy Yields Additive Effect
   • Human-Derived SOD1 Antibodies Show Promise in ALS Mice
   • Safe at 4 Grams? No ARIA at High Dose of Human Aβ Antibody
2. International Conference on Alzheimer's & Parkinson's Diseases 2011
   • Barcelona: 10th AD/PD Conference Hosts a Shaken, Restive Field
   • Barcelona: Straight Talk From a Regulator on Trials in Parkinson’s
   • Barcelona: Taking Parkinson’s Research From Movement to Mind
   • Barcelona: What Lies Beyond Genomewide Association Studies?
   • Barcelona: Stocking Biomarker Arsenal for Lewy Body Dementia
   • Barcelona: Out of Left Field—Hit to The Eye Kills BACE Inhibitor
   • Barcelona: Live and Learn—γ-Secretase Inhibitors Fade, Modulators Rise
   • Barcelona: Allosteric γ Modulation Moves Toward Clinic
   • Barcelona: Is Parkinson’s Pathology Treatable?
   • Barcelona: Parkinson’s Treatments on the Horizon
   • Barcelona: Antibody to Sweep Up Aβ Protofibrils in Human Brain
   • Barcelona: A Fistful of Schemes for Tackling Alzheimer’s
   • Barcelona: Inflammation—That Two-Faced Beast
3. International Conference on Alzheimer's & Parkinson's Diseases 2007
   • Salzburg Overview: 8th International Conference Draws Record Number
   • Salzburg: New Proteins Redefine Frontotemporal Dementias
   • Salzburg: Getting to Know Progranulin, the New Heavy
   • Salzburg: Protein Trio Offers Handle on Elusive ERAD
   • Salzburg: The Pony in There—Can ACAT Inhibition Work for AD?
   • Salzburg: At Five, Amyloid Imaging Registers Growth Spurt
   • Salzburg: Amyloid Imaging Update
   • Salzburg: Like PD, Like AD—New Tau Mice Draw Notice
   • Salzburg: Aβ’s N-terminal Shenanigans
4. International Conference on Alzheimer's & Parkinson's Diseases 2005
   • Sorrento: Immunotherapy Update Hot Off Lectern of AD/PD Conference
   • Sorrento: Scientists Stop Clubbing, Start Tweaking, γ-Secretase
   • Sorrento Secretase News: Baiting β, Awakening α
   • Sorrento: More Fun, Less Amyloid for Transgenic Mice
   • Sorrento: They’ve Just Got to Have It—Where’s That Biomarker? Part 1
   • Sorrento: They’ve Just Got to Have It—Where’s That Biomarker? Part 2
   • Sorrento: Sorting Out Shedding of Ectodomains
   • Sorrento: ADNI Imagines the Future of AD Imaging
   • Sorrento: Trouble with the Pro’s
   • Sorrento: Tumor Suppressor Ties Miscreant Kinase to Cell Cycle
   • Sorrento: More Mice and Men—What Role ApoE in Vascular Dementia?
5. International Conference on Alzheimer's & Parkinson's Diseases 2003
   • Notes from International AD/PD Conference 2003 in Seville